SCHEMBL15911343

SCHEMBL15911343

COC(=O)C1(c2ccc(Oc3cc(Oc4ccc(Br)cc4)cc([N+](=O)[O-])c3)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 8/20 0.43
▸ MAPT P10636 6/20 0.43
▸ MEN1 O00255 9/20 0.42
▸ KMT2A Q03164 9/20 0.42
▸ MMP2 P08253 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ TBXA2R P21731 1/20 0.39
▸ HPGD P15428 4/20 0.39
▸ NPSR1 Q6W5P4 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ HTT P42858 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ MITF O75030 1/20 0.38
▸ S1PR4 O95977 1/20 0.38
▸ S1PR1 P21453 1/20 0.38
▸ NTSR1 P30989 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1465773 0.79 MEN1 (0.54) LMNAMAPTMEN1KMT2ANPSR1
SCHEMBL349353 0.78 HDAC1 (0.42) LMNAMAPTMEN1KMT2AHPGD
SCHEMBL14712065 0.74 HRH3 (0.45) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL3227451 0.73 MEN1 (0.58) LMNAMAPTMEN1KMT2ANPSR1
SCHEMBL3052103 0.73 HDAC1 (0.47) LMNAMAPTALDH1A1MAPK1SMN1; SMN2
SCHEMBL3054538 0.73 HDAC1 (0.50) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL3049424 0.72 HDAC1 (0.51) LMNAMAPTALDH1A1MAPK1HTT
SCHEMBL15054845 0.71 KDM1A (0.47) LMNAMAPTMEN1KMT2AHPGD
SCHEMBL14790321 0.71 OPRM1 (0.42) LMNAMAPTMEN1KMT2ANPSR1
SCHEMBL3903075 0.70 L3MBTL1 (0.58) LMNAMAPTMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10835520-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2020-11-17 — — US disclosed
US-20190030010-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2019-01-31 — — US disclosed
US-10117861-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2018-11-06 — — US disclosed
EP-3150577-B1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-08-29 — — EP disclosed
US-20180042908-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2018-02-15 — — US disclosed
US-9820980-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-11-21 — — US disclosed
EP-3150577-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2017-04-05 — — EP disclosed
US-20160213660-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-07-28 — — US disclosed
US-9340499-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2016-05-17 — — US disclosed
US-20150126486-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2015-05-07 — — US disclosed
US-8975409-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2015-03-10 — — US disclosed
US-20140235611-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2014-08-21 — — US disclosed
EP-2762466-A1 PHENYL DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2014-08-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10117861-B2 Phenyl derivative S1PR2, S1PR1, S1PR3 LMNA 1664/4885MAPT 4752/4885MEN1 1010/4885
US-20150126486-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1797/4885MAPT 4759/4885MEN1 1038/4885
US-20180042908-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1664/4885MAPT 4752/4885MEN1 1010/4885
US-20190030010-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1664/4885MAPT 4752/4885MEN1 1010/4885
US-20160213660-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1664/4885MAPT 4752/4885MEN1 1010/4885
US-20140235611-A1 PHENYL DERIVATIVE S1PR2, S1PR1, S1PR3 LMNA 1797/4885MAPT 4759/4885MEN1 1038/4885
US-10835520-B2 Phenyl derivative S1PR2, S1PR1, S1PR3 LMNA 1664/4885MAPT 4752/4885MEN1 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback